 |
|
|
|
|
| |
 |
|
|
| |
Boston Millennia Partners’ portfolio reflects Millennia’s commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors. Millennia’s portfolio is comprised of a diversified group of firms each positioned with the potential to become leaders in their respective market segments. We invite you to use the links below to learn more about each of those portfolio companies. |
|
| |
|
|
| |
| |
|
|
|
| |
|
| |
|
|
eMed Technologies provides services, software and networking with communications infrastructure products to radiology centers and healthcare professionals that need to manage, distribute, and access medical images and related information. |
|
|
| |
|
|
Galt Associates is a pharmacovigilance support company, specializing in the delivery of web-based compliance and analysis solutions for the pharmaceutical industry. Their solutions allow pharmaceutical companies to better understand drug safety issues through the management of safety data and adverse event reporting. Customers include 17 of the world's top 20 pharmaceutical companies. |
|
|
| |
|
|
MedAptus (formerly MedCompanion) is a Healthcare information technology company that empowers physicians to recapture revenues and lost time by providing customized workflow applications for wireless, handheld technologies. |
|
|
| |
|
|
Medical Management of New England was a specialist in account receivables management for New England based medical practices, managing all of a client's receivables operations, from billing to collection. The company was sold to Medaphis in June, 1993 and changed its name to Per-Se Technologies in 1999. ( Nasdaq: PSTI ). |
|
|
| |
|
|
MedSpan was a private Connecticut-based provider-sponsored health maintenance organization participating in both the commercial and Medicare Risk sectors. The company was sold to Oxford Health Plans on March 13, 2002. ( Nasdaq: OHP ) With the completion of this acquisition, MedSpan enabled Oxford to expand its provider, hospital and member network. Before being acquired, MedSpan’s 2001 full-year commercial revenues were $128.1 million. |
|
|
| |
|
|
PAREXEL is a public Core Company formed as a global, full service Contract Research Organization (CRO) specializing in comprehensive clinical trials management, biostatistical consultation, and regulatory submissions for pharmaceutical, biotechnology, medical device, and other health related industries. Public since November, 1995 (Nasdaq: PRXL). |
|
|
| |
|
|
PHT provides mobile and Web technologies that help pharmaceutical companies simplify clinical trials by dramatically improving the process of collecting and managing accurate clinical trial data. |
|
|
| |
|
|
Proteome, acquired by Incyte Corporation in 2000, sells value-added proprietary protein databases to pharmaceutical and biotechnology companies. The company's databases aggregate curated and annoted protein literature with analysis tools to determine protein function from genomic information for drug discovery. |
|
|
|
|
|
|
|
|
